Toshinao Kanazawa
Osaka City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshinao Kanazawa.
European Urology | 1993
Toshikado Sugimoto; Osswald H; Keisuke Yamamoto; Toshinao Kanazawa; Iimori H; Funae Y; Kamikawa S; Taketoshi Kishimoto
The pharmacokinetics of oxalate were studied in normal and nephrectomized rats with the use of radioisotope-labelled oxalate. The disappearance of [14C]oxalate from the plasma was analyzed with a two-compartment open model. The pharmacokinetic parameters of oxalate were compared with those for inulin. In normal rats, the plasma half-life of the elimination of oxalate was 0.33 +/- 0.06 h and that for inulin was 0.26 +/- 0.05 h (n = 10, mean +/- SD). The volume of distribution for oxalate was 56.7 +/- 6.80 and that for inulin 34.0 +/- 4.79 ml/100 g body weight, indicating that oxalate has access to additional compartments besides the extracellular volume. The total clearance of oxalate was 1.2 times higher than that for inulin. In nephrectomized rats, however, the plasma half-life of the elimination of oxalate was 1.85 +/- 0.34 h (n = 7, mean +/- SD) and that for inulin was 4.26 +/- 0.78 h. The total clearance of oxalate was 177 +/- 29 and that for inulin was 30 +/- 5 microliters/min/100 g body weight. In order to identify the extrarenal elimination route of oxalate, the bile of nephrectomized rats was collected. The hepatic clearance of oxalate was 31.2 +/- 2.7 microliters/min/100 g body weight. The biliary excretion of oxalate accounts for 17.6% of the total clearance in nephrectomized rats. Thus, other elimination processes of oxalate besides renal and hepatic clearance take place.
International Journal of Urology | 2003
Tatsuya Nakatani; Keiichi Ishii; Toshikado Sugimoto; Sadanori Kamikawa; Keisuke Yamamoto; Yukio Yoneda; Toshinao Kanazawa; Taketoshi Kishimoto
Abstract Background: The kidney eliminates the major fraction of plasma oxalate. It is well known that oxalate is freely filtered by glomeruli and secreted by the proximal tubules. However, the renal handling of oxalate in distal nephrons, which is considered as playing an important role in stone formation, remains obscure.
Archive | 1994
Toshinao Kanazawa; Toshikado Sugimoto; Sadanori Kamikawa; Hiroki Iimori; Keisuke Yamamoto; Tatsuya Nakatani; Hartmut Oßwald; Yoshihiko Funae; Taketoshi Kishimoto
It is known that the deposition of calcium oxalate crystals in the kidney is the first stage of stone formation. However, the exact location of this deposition in the kidney has not been determined. Hautmann and Oswald1 pointed out that there was a concentration gradient of oxalate and calcium from cortex to medulla of the kidney, and that oxalate and calcium contents in the papilla were hundred times higher than those in urine. These findings indicated that the renal papilla, especially the interstitium of papilla might be the site of the calcium oxalate crystalluric deposition. In the present study, we performed autoradiographic studies on oxalate in hyperoxaluric rats using 14C-oxalate, in order to elucidate the distribution of oxalate in renal tissue and the site of the deposition of calcium oxalate crystals along the nephron.
Archive | 1989
Toshikado Sugimoto; H. Osswald; Taketoshi Kishimoto; Keisuke Yamamoto; Toshinao Kanazawa; H. Rübben; T. Matsumura
We have already reported pharmacokinetic studies of oxalate in rats using radio-isotopes; oxalate is more diffusible through biological membranes than inulin, and oxalate is excreted mainly by the kidney, although some is excreted by the liver (Sugimoto et al. 1988). Here, we checked these results in an autoradiographic study of oxalate in rats. Autoradiograms made after an injection of [14C]oxalate were com-pared with those made after an injection of [14C]inulin.
Archive | 1989
Seiji Wada; Taketoshi Kishimoto; Yasushi Ameno; Toshinao Kanazawa; Keisuke Yamamoto; Masanobu Maekawa; Hiroki Iimori; Shinichi Ikemoto
Peripheral blood mononuclear cells (PBMN) from healthy donors and urolithiasis patients before and after extracorporeal shock wave lithotripsy (ESWL*) or transurethral ureterolithotripsy (TUL) were harvested using Ficoll-Paque gradient in order to study the effects of shock waves on PBMN.
Urological Research | 2002
Tatsuya Nakatani; Keiichi Ishii; Yukio Yoneda; Sadanori Kamikawa; Toshinao Kanazawa; Toshikado Sugimoto; Hartmut Oßwald
The Japanese Journal of Urology | 1996
Sadanori Kamikawa; Toshikado Sugimoto; Toshinao Kanazawa; Keiichi Ishii; Yukio Yoneda; Hiroki Iimori; Keisuke Yamamoto; Taketoshi Kishimoto; Yoshihiko Funae
The Japanese Journal of Urology | 1990
Sakamoto W; Taketoshi Kishimoto; Keisuke Yamamoto; Toshikado Sugimoto; Masaaki Senju; Hiroki Iimori; Toshinao Kanazawa; Seiji Wada; Masanobu Maekawa
International Journal of Urology | 1996
Keiichi Ishii; Toshikado Sugimoto; Toshinao Kanazawa; Yukio Yoneda; Sadanori Kamikawa; Hiroki Limori; Tatsuya Nakatani; Keisuke Yamamoto; Taketoshi Kishimoto
Japanese journal of endourology and ESWL | 1995
Seiji Wada; Sakamoto W; Toshinao Kanazawa; Takahisa Terada; Keisuke Yamamoto; Taketoshi Kishimoto